A Prospective Study of Tangwang prescription in the Treatment of Non-Proliferative Diabetic Retinopathy
Phase 1
Recruiting
- Conditions
- on-Proliferative Diabetic Retinopathy
- Registration Number
- ITMCTR2022000020
- Lead Sponsor
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Xicheng District, Beijing
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Meet the diagnostic criteria for type 2 diabetic retinopathy, the degree of the disease is non-proliferative (at least one eye meet)
(2) Age 30-70 years
Exclusion Criteria
(1)Other ophthalmic diseases that do not belong to diabetic retinopathy, such as non-diabetic retinopathy, uveitis, retinal detachment, optic nerve disease and high myopia with fundus lesions;
(2)meet the diagnostic criteria for diabetic retinopathy, but the degree of the disease was proliferative.
(3)Type 1 diabetic retinopathy.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction rate and aggravation rate of diabetic retinopathy;
- Secondary Outcome Measures
Name Time Method Blood pressure;Number of retinal microangiomas, hemorrhages, and exudates;Incidence of endpoint events;Symptom relief;Lipids;Change in the degree of macular edema;Fasting plasma glucose;